SEC Form 4 · accession 0001185185-17-002561
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Dec 4, 2017
Accepted (ET)
Dec 5, 2017 · 6:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2017 | S | 30 | $0.56 | D | 438,970 | D | |
| Common Stock | Dec 4, 2017 | S | 1,200 | $0.56 | D | 437,770 | D | |
| Common Stock | Dec 4, 2017 | S | 600 | $0.56 | D | 437,170 | D | |
| Common Stock | Dec 4, 2017 | S | 100 | $0.55 | D | 437,070 | D | |
| Common Stock | Dec 4, 2017 | S | 500 | $0.55 | D | 436,570 | D | |
| Common Stock | Dec 4, 2017 | S | 100 | $0.55 | D | 436,470 | D | |
| Common Stock | Dec 4, 2017 | S | 22,470 | $0.55 | D | 414,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
THIS FORM 4 IS A CONTINUATION OF THE FORM 4 FILED IMMEDIATELY PRIOR. THE FILINGS WERE SEPARATED DUE TO INSUFFICIENT ROOM ON THE FIRST FILING TO SUPPLY ALL OF THE DATA.